MLICM
CMRX

Metropolitan Life Insurance Company (MetLife)’s Chimerix, Inc. CMRX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,266
Closed -$9.79K – 2483
2022
Q4 		$9.79K Buy
+5,266
New +$10.3K ﹤0.01% 2287
2022
Q2 		– Sell
-4,986
Closed -$22.8K – 2445
2022
Q1 		$22.8K Sell
4,986
-8,129
-62% -$45.3K ﹤0.01% 2024
2021
Q4 		$84.3K Buy
13,115
+3,295
+34% +$19.8K ﹤0.01% 2566
2021
Q3 		$60.8K Sell
9,820
-7,929
-45% -$54.5K ﹤0.01% 2739
2021
Q2 		$142K Buy
17,749
+1,826
+11% +$15.2K ﹤0.01% 2400
2021
Q1 		$153K Buy
+15,923
New +$146K ﹤0.01% 2193
2018
Q2 		– Sell
-17,118
Closed -$89K – 2500
2018
Q1 		$89K Buy
+17,118
New +$86.7K ﹤0.01% 2341
2017
Q4 		– Sell
-35,342
Closed -$186K – 2528
2017
Q3 		$186K Sell
35,342
-122
-0.3% -$600 ﹤0.01% 2312
2017
Q2 		$193K Buy
35,464
+96
+0.3% +$505 ﹤0.01% 2356
2017
Q1 		$226K Buy
+35,368
New +$201K ﹤0.01% 2194
2016
Q4 		– Sell
-36,121
Closed -$200K – 2646
2016
Q3 		$200K Buy
+36,121
New +$165K ﹤0.01% 2336
2016
Q2 		– Sell
-32,126
Closed -$164K – 2694
2016
Q1 		$164K Hold
32,126
– – ﹤0.01% 2283
2015
Q4 		$288K Hold
32,126
– – ﹤0.01% 1998
2015
Q3 		$1.23M Buy
32,126
+3,227
+11% +$159K 0.01% 1089
2015
Q2 		$1.33M Buy
28,899
+5,471
+23% +$219K 0.01% 1123
2015
Q1 		$883K Hold
23,428
– – 0.01% 1269
2014
Q4 		$943K Buy
23,428
+2,192
+10% +$74.2K 0.01% 1352
2014
Q3 		$587K Hold
21,236
– – ﹤0.01% 1616
2014
Q2 		$466K Buy
21,236
+13,593
+178% +$270K ﹤0.01% 1875
2014
Q1 		$175K Buy
+7,643
New +$154K ﹤0.01% 2551
2013
Q4 		– Sell
-7,608
Closed -$167K – 2763
2013
Q3 		$167K Sell
7,608
-2,446
-24% -$50.3K ﹤0.01% 2549
2013
Q2 		$244K Buy
+10,054
New +$210K ﹤0.01% 2211

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CMRX Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Chimerix, Inc. (CMRX) in Q1 2023, closing a stake of 5,266 shares — an estimated $9.79K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CMRX in Q2 2013 and held it in 22 quarters. The position peaked at $1.33M in Q2 2015. 97 funds tracked by Wall St. Rank hold CMRX as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Chimerix, Inc. position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,266 Chimerix, Inc. shares in Q1 2023, an estimated $9.79K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Chimerix, Inc. in Q2 2013 and held it in 22 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Chimerix, Inc. position peaked at $1.33M in Q2 2015.
  • 97 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.